Evidence map›Paper›PMID 31317521›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2020

Prognostic factors for the survival of patients with papillary renal cell carcinoma after surgical management.

W Ren, X Gao, X Zhang, J Hu, H Li, X Zu

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

W RenDepartment of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
X GaoDepartment of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
X ZhangDepartment of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
J HuDepartment of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
H LiDepartment of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
X ZuDepartment of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China. zuxbxyyy@126.com.ORCID http://orcid.org/0000-0001-6346-6674
Central South University · CN

Funding

National Key R&D Program of China 2016YFC0902603National Natural Science Foundation of China 81572523
6 · The paper itself

Abstract

purposeTo examine the possible prognostic factors in patients with type 1 and type 2 papillary renal cell carcinoma (pRCC) after surgical management and to identify the independent predictive factors of the prognosis.

methodsFrom 2010 to 2017, 1405 patients underwent surgery for renal cell carcinoma, of whom 114 had type 1 or type 2 pRCC and follow-up data were available for 88 patients. Clinicopathological and prognostic parameters were compared between type 1 and type 2 pRCC. Possible prognostic factors were retrospectively analyzed by univariate and multivariate analyses with Cox regression.

resultsThe study included 63 males and 25 females with a mean age of 54.27 ± 12.91. 53 patients were diagnosed by regular physical examination and others presented with hematuria or lumbago. 53 (60.2%) underwent radical nephrectomy and 35 (39.8%) underwent nephron sparing surgery. After a mean follow-up of 46.08 ± 22.65 months, 16 patients died of pRCC metastasis and the 5-year disease-specific survival was 79.3%. The comparison of the 39 (44.3%) type 1 and 49 (55.7%) type 2 pRCCs revealed that type 2 pRCC had significantly higher grade and worse prognosis. Univariate analysis showed that symptomatic diagnosis, type, grade, and tumor stage were prognostic factors. Multivariate analysis identified that type and tumor stage were independent factors of the prognosis.

conclusionsPathological type and tumor stage could serve as independent factors for the prognosis of patients with pRCC.

Indexed as

AdultAgedCarcinoma, Renal CellDisease-Free SurvivalFemaleHumansKidney NeoplasmsMaleMiddle AgedMultivariate AnalysisNephrectomyPrognosisRetrospective StudiesSurvival RatePapillary renal cell carcinomaPathologyPrognosisSurvival

Identifiers

PMID31317521
OpenAlexW2957427472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.